H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)

Weakness in this biotech stock is a buying opportunity: Mizuho

July 31, 2026 9:00 AM EDT

Mizuho reiterated an Outperform rating and $65 price target on a key biotech stock in a note on Friday, telling investors that a selloff following the drugmaker's second-quarter results is a buying opportunity.

Analyst Uy Ear said Alkermes (NASDAQ: ALKS) posted a solid quarter, with product sales, manufacturing and royalty revenues broadly in line with estimates... More